Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

328 results about "Ester hydrolysis" patented technology

Magnetic fluorescent composite nanoparticle, as well as preparation and use thereof

The invention discloses a magnetic luminescent composite nano-particle Fe3O4 / CdTe / SiO2 and a preparation method thereof. The method for preparing the magnetic luminescent composite nano-particle Fe3O4 / CdTe / SiO2 comprises the steps of: firstly preparing hydrophobic monodisperse Fe3O4 nano-particles by adopting a chemical oil-phase high-temperature method, and modifying the surfaces of the hydrophobic Fe3O4 nano-particles to ensure that the hydrophobic Fe3O4 nano-particles are dispersed in a water phase; preparing luminescent CdTe quantum dots of which the surfaces are provided with carboxyl groups, and precipitating the luminescent CdTe quantum dots on the surfaces of the magnetic Fe3O4 nano-particles through the co-precipitation; then utilizing ligand exchange to modify a silane coupling agent on the surfaces of the luminescent CdTe quantum dots; and finally forming an outermost SiO2 coating layer through silane or silicon ester hydrolysis. The diameter of the magnetic luminescent composite nano-particle Fe3O4 / CdTe / SiO2 is between 30 and 50nm; the magnetic luminescent composite nano-particle Fe3O4 / CdTe / SiO2has double functions of magnetism and fluorescence at the same time, has strong and durable fluorescence intensity after labeling rat bone marrow-derived mesenchymal stem cells, and apparently reduces cellular magnetic resonance signals. The particle has broad application prospect in the fields such as biological labeling, bioseparation and the like.
Owner:SUN YAT SEN UNIV

Stable pharmaceutical compositions containing an ACE inhibitor

A stable pharmaceutical composition comprising about 1 wt. % to about 80 wt. % of an ACE inhibitor or a pharmaceutical acceptable salt thereof, about 1 wt. % to about 70 wt. % of an alkali or alkaline earth metal carbonate, and about 1 wt. % to about 80 wt. % of hydroxypropyl cellulose, wherein the ACE inhibitor is selected from the group consisting of quinapril, enalapril, spirapril, ramipril, perindopril, indolapril, lisinopril, alacepril, trandolapril, benazapril, libenzapril, delapril, cilazapril and combinations thereof; wherein the formation of an internal cyclization product, and / or ester hydrolysis product, and / or oxidation product, has been reduced or eliminated, and the weight percents are based on the total weight of the pharmaceutical composition. The stabilized pharmaceutical compositions of the invention exhibit a number of advantages as follows: (i) the ACE inhibitor or a pharmaceutical acceptable salt thereof present in the compositions is preserved from degradation; (ii) the compositions exhibit extended shelf-life under normal storage conditions; (iii) the effect of moisture on the compositions is minimized; (iv) the compositions exhibit minimal, if any, discoloration over a significant period of time; and (v) the compositions exhibit minimal, if any, instability when employed in the presence of colorants.
Owner:SANDOZ AG

Castor oil-based hydrophilic chain extender as well as preparation method and application thereof

The invention discloses a castor oil-based hydrophilic chain extender as well as a preparation method and application thereof. According to the castor oil-based hydrophilic chain extender, starting from castor oil, one of the renewable resources, a hydroxyl group is introduced by mercapto group-ene light click reaction to obtain an intermediate, and then a carboxyl group is generated through hydrolysis reaction of an ester group (or ricinoleic acid is generated through ester hydrolysis reaction of castor oil first, and then the hydroxyl group is introduced by mercapto group-ene light click reaction), the hydrophilic chain extender containing at least two hydroxyl groups and a carboxyl group is prepared, and the hydrophilic chain extender is applied to preparation of anionic aqueous polyurethane emulsion. According to the castor oil-based hydrophilic chain extender as well as the preparation method and the application thereof, the castor oil is applied to hydrophilic chain extender rawmaterials, has positive reference value for broadening application and increasing added value of natural fat products and also plays a positive role in reducing or replacing an environment problem caused by the use of petroleum non-renewable resources. The castor oil-based hydrophilic chain extender prepared by the invention is liquid at normal temperature, a contact area with other raw materialsduring a reaction is larger, the mixing is more uniform and the reaction speed is higher.
Owner:SOUTH CHINA AGRI UNIV

Stable pharmaceutical compositions containing an ace inhibitor

A stable pharmaceutical composition comprising about 1 wt. % to about 80 wt. % of an ACE inhibitor or a pharmaceutical acceptable salt thereof, about 1 wt. % to about 70 wt. % of an alkali or alkaline earth metal carbonate, and about 1 wt. % to about 80 wt. % of hydroxypropyl cellulose, wherein the ACE inhibitor is selected from the group consisting of quinapril, enalapril, spirapril, ramipril, perindopril, indolapril, lisinopril, alacepril, trandolapril, benazapril, libenzapril, delapril, cilazapril and combinations thereof; wherein the formation of an internal cyclization product, and/or ester hydrolysis product, and/or oxidation product, has been reduced or eliminated, and the weight percents are based on the total weight of the pharmaceutical composition. The stabilized pharmaceutical compositions of the invention exhibit a number of advantages as follows: (i) the ACE inhibitor or a pharmaceutical acceptable salt thereof present in the compositions is preserved from degradation; (ii) the compositions exhibit extended shelf-life under normal storage conditions; (iii) the effect of moisture on the compositions is minimized; (iv) the compositions exhibit minimal, if any, discoloration over a significant period of time; and (v) the compositions exhibit minimal, if any, instability when employed in the presence of colorants.
Owner:SANDOZ AG

Phase-change heat storage insulation coating based on phase-change heat storage as well as preparation method and application of coating

The invention discloses a paraffin / SiO2-TiO2 phase-change microcapsule. According to the microcapsule, a phase-change material is formed by paraffin or a fatty acid and other organic phase-change materials; SiO2 generated due to the hydrolysis of tetraethyl orthosilicate is taken as a backing material of the phase-change material; TiO2 generated due to the hydrolysis of tetrabutyl titanate is taken as a modified material of a reflecting property. The invention further discloses a phase-change heat storage insulation coating based on phase-change heat storage as well as a preparation method and an application of the coating. The paraffin / SiO2-TiO2 phase-change microcapsule is prepared by carrying out the following steps: wrapping the paraffin by utilizing the excellent mechanical property of SiO2 and then depositing TiO2 on the surface layer of the phase-change microcapsule. Thus, the phase-change microcapsule with a composite structure is good in mechanical property and excellent in optical property. The prepared phase-change heat storage insulation coating is good in heat storage and heat insulation, and can be used for effectively improving the heat comfortability of a building and lowering the energy consumption of the building.
Owner:SOUTHEAST UNIV

Specific fluorescence probe substrates of human carboxylesterase 2 and application thereof

The invention provides a specific fluorescence probe substrates of human carboxylesterase 2 (CES2) and application thereof. The specific probe substrate is a benzoateb compound of a C4 hydroxyl naphthalimide, and is applicable to determine the enzyme activity of CES2 in a biological system. The CES2 enzyme activity determination flow comprises: selecting a hydrolysis benzoyl-removal reaction of the benzoate compound of the C4 hydroxyl naphthalimide as a probe reaction, and quantitatively determining the generation amount of a hydrolysis metabolite of the compound in a unit time, so as to determine the enzyme activity of CES2 in all biological samples, cells, bodies and integral organs. The probe is applicable to quantitative assessment of CES2 enzyme activity in biological samples of different species and different individual sources, and quantitative determination on CES2 enzyme activity in different sources of animal tissue cell culture fluids and cell preparation substances, so that the probe is expected to help to realize assessment on medicine disposal capability of important drug metablic enzyme CES2. Additionally, the probe also is applicable as an inhibitor for rapidly screening CES2 in vitro by means of the probe reaction.
Owner:DALIAN INST OF CHEM PHYSICS CHINESE ACAD OF SCI

Proteolysis micro-fluidic chip based on silica gel oxidized graphene composite membrane and fabrication method of proteolysis micro-fluidic chip

The invention belongs to the technical field of micro-fluidic chips, and particularly relates to a proteolysis micro-fluidic chip based on a silica gel oxidized graphene composite membrane and a fabrication method of the proteolysis micro-fluidic chip. The fabrication method comprises the steps that chemical oxidization and ultrasonic dispersion are conducted on graphite powder, and an oxidized graphene aqueous solution is obtained; the oxidized graphene aqueous solution is mixed with a silica solution prepared by hydrolyzing n-silicane ethyl ester, and injected into an organic glass micro-fluidic chip channel with the surface subjected to silica gelation treatment; a modification solution is removed after a certain time; a micro-fluidic chip modified with the silica gel oxidized graphene composite membrane is obtained after drying; then, a mixed solution of 1-(3-dimethyl aminopropyl)-3-ethyl carbodiimide hydrochloride and N-hydroxyl succinimide is injected into the channel to allow carboxyl of oxidized graphene on the surface of the channel to be activated; a protease solution such as trypsin is injected to allow protease to be fixed by a covalent bond; and the proteolysis micro-fluidic chip is obtained. A micro-fluidic chip proteolysis reactor has the advantages of short enzymolysis time, low sample consumption, cheap price and the like.
Owner:FUDAN UNIV

Au/TiO2/metal-organic framework composite photocatalyst, preparation method therefor and application of Au/TiO2/metal-organic framework composite photocatalyst

The invention belongs to the field of preparation and application of composite photocatalytic materials and particularly relates to an Au/TiO2/metal-organic framework composite photocatalyst and preparation and application of the Au/TiO2/metal-organic framework composite photocatalyst. The preparation comprises the steps: preparing monodisperse cation polystyrene microspheres from styrene and methylacryloyloxy trimethylammonium chloride, which serve as monomers, and then, forming cobalt metal-organic frameworks on surfaces of the polystyrene microspheres by a layer-by-layer assembling method in a manner of taking the polystyrene microspheres as a template, so as to prepare styrene-cobalt metal-organic framework core-shell structures; carrying out hydrolysis by tetrabutyl titanate in the presence of ammonia water, so as to prepare TiO2-loaded mono-styrene-cobalt metal-organic framework core-shell structures; further, carrying out ultraviolet irradiation to photocatalytically reduce Au<3+> into Au, so as to modify TiO2; and finally, removing polystyrene cores, thereby obtaining the Au/TiO2/metal-organic framework composite photocatalyst. The catalyst has the characteristics of low density, large specific surface area, no agglomeration, stable catalytic performance, high photocatalytic activity, and the like.
Owner:湖州肖圣科技有限公司

Ultrahigh-transparency large-size block silicon dioxide aerogel and preparation method and application thereof

ActiveCN112174144AControllable adjustment of reactivityImprove uniformitySilicon compoundsPtru catalystSilicic acid
The invention relates to an ultrahigh-transparency large-size block silicon dioxide aerogel and a preparation method and application thereof. The method comprises the following steps: uniformly mixingtetramethyl orthosilicate, long-chain alkyl trimethoxy silane, an alcohol solvent, water and an alkali catalyst, carrying out hydrolysis reaction to obtain sol, and putting the sol into a mold to carry out sol-gel reaction to obtain wet gel; carrying out gradient heating aging on the wet gel to obtain skeleton-reinforced wet gel; and sequentially carrying out solvent replacement and supercriticaldrying on the skeleton-reinforced wet gel to obtain the ultrahigh-transparency large-size block silicon dioxide aerogel. According to the preparation method disclosed by the invention, superfine silicon dioxide sol generated by hydrolyzing long-chain alkyl trimethoxy silane stable tetramethyl orthosilicate is introduced, and the reaction activity of the sol is controllably adjusted so that the accurate regulation and control of a gelling process are realized; the aerogel prepared by the method has the characteristics of ultrahigh transparency, large size, super heat insulation capability, super hydrophobicity and the like, and has great economic value in the field of transparent heat insulation.
Owner:AEROSPACE INST OF ADVANCED MATERIALS & PROCESSING TECH

SiO2-coating-based preparation method of carbonyl iron powder composite wave-absorbing material

The invention provides an SiO2-coating-based preparation method of a carbonyl iron powder composite wave-absorbing material. The preparation method comprises the steps that S1, carbonyl iron powder isadded into deionized water to form a mixture, the mass percent of the carbonyl iron powder is 1%-5%, and ultrasonic treatment is conducted on the mixture for 1-2 min to obtain a system A; S2, tetraethoxysilane and a silane coupling agent are added into absolute ethyl alcohol to form a mixture, the mass percents of the tetraethoxysilane and the silane coupling agent are both 0.5%-2%, and a systemB is obtained; S3, the system A and the system B are mixed, then a catalyst for facilitating hydrolysis of tetraethoxysilane is added into the mixture, mixed liquid is formed, the mass percent of thecatalyst is 0.2%-1%, the mixed liquid is subjected to thermostatic water-bath heating for 2-4 h under stirring of a magnetic stirrer, and water-bath temperature is 40-60 DEG C; S4, supernatant in themixed liquid is poured out, lower layer precipitates are washed repeatedly through deionized water, and the carbonyl iron powder is gathered constantly through magnetism of the magnetic stirrer; and S5, products obtained in S4 are subjected to vacuum drying for 18-24 h under the condition of 50-70 DEG C, then grinding is conducted for 4-6 min, and operation is completed. The wave-absorbing material prepared through the preparation method has good wave-absorbing performance.
Owner:HARBIN INST OF TECH AT WEIHAI +1

Preparation process of insulin sensitizer

InactiveCN104744282AHigh yieldAvoid conditions that are prone to hydrolysisOrganic compound preparationSulfonic acid esters preparationCyclohexanoneNitrogen gas
The invention discloses a preparation process of an insulin sensitizer. The preparation process comprises the following steps: mixing 2-(4-fluorobenzoyl) cyclohexanone, L-tyrosine methyl ester, dioxane and methylbenzene, filling nitrogen and reacting, carrying out a distilling procedure, and reacting with the addition of anisole and palladium/carbon so as to obtain a first product; mixing the first product with dichloromethane, adding methylsufonyl chloride and pyridine, reacting, distilling and removing dichloromethane so as to obtain a second product; mixing for reacting the second product with tetrahydrofuran and 1,2-dibromoethane, and thinning with water so as to obtain a third product; and mixing for reacting the third product with salt, cuprous chloride, carbazole, 8-hydroxyquinoline and dimethyl sulfoxide, thinning with water and extracting with ethyl acetate, distilling and removing ethyl acetate so as to obtain a final product, namely 2-[2-(4-fluorobenzoyl) aniline]-3-[4-(2-carbazolyl ethyoxyl) phenyl] methyl propionate. The yield of the final product is 47%; and in the process of joining the final product and carbazole, the circumstance of ester hydrolysis in a synthesis reaction of the novel insulin sensitizer, namely chiglitazar, is avoided.
Owner:NANTONG HENGSHENG FINE CHEM
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products